What will be the proper mix in different risk groups, in different subtypes, in different backgrounds if the goal is to reach a vaccine -- one vaccine -- that could work for all people and nations?" But the researchers say the findings offer new hope for AIDS research.
VOA: standard.2009.10.20
Patients with mixed cellularity or lymphocyte deplete subtypes of HL often have HL involving the liver.